Top 10 Stock Market Highlights for Monday: What You Can’t Afford to Miss
As the sun rises on another trading week, there are significant developments in the stock market that investors and enthusiasts alike need to keep a close eye on. Below are the top 10 market trends and events to watch this Monday, May 12, that could shape your portfolio for the days ahead.
1. U.S. and China Make Terrific Trade Moves
In a surprising turn of events, the United States and China have agreed to significantly reduce their reciprocal tariff rates. The new U.S. tariff on Chinese imports is set to drop to 30% from 145%, while China will lower its duty on American goods to 10% from 125%. This temporary slashing offers a glimmer of hope as a more comprehensive trade agreement is in the works.
2. Companies Poised to Benefit from Thawing Trade Tensions
The easing trade tensions bode well for companies that manufacture in China and sell in the U.S. Lower-end semiconductors, stylish sneakers, and the ever-popular (Apple’s products) can expect a boost. Boeing may also see a positive shift, especially after dealing with the return of airplanes from China last month.
3. Market Futures Skyrocket
Thanks to the uplifting trade news, stock futures have surged. The S&P 500 is projected to open up by 3%, while the Dow Jones could see a 1,100-point rise. The tech-heavy Nasdaq 100 is leading the charge, with an impressive 4% gain.
4. Market Sentiment and Short Positions
Despite the optimistic news, there is a notable short position against the market. Skeptical views from billionaire investor Paul Tudor Jones suggest that the market could hit new lows, even if tariffs are cut dramatically. This speaks to a broader drumbeat of negativity that may dampen enthusiasm among younger and retiree investors.
5. Trump’s Drug Pricing Executive Order
In today’s political arena, President Trump is expected to sign an executive order aimed at reducing drug prices to align with those of other high-income nations. While specifics remain vague, this move may ignite a fierce legal battle, giving pharmaceutical companies the upper hand in court.
6. Pharma Stocks Face Pressure Amid Price Cuts
As a result of the potential drug pricing overhaul, pharma stocks are under pressure this morning. Giants like Pfizer, AbbVie, and Merck are all facing declines. However, there’s a silver lining for Eli Lilly, as new trial data indicates its obesity drug, Zepbound, outperforms Novo Nordisk’s Wegovy.
7. Johnson Controls Gets a Boost
Deutsche Bank has upgraded Johnson Controls to a buy rating from a hold, signaling potential growth in the industrial sector. However, when it comes to industrial companies with a data center focus, I prefer Eaton and Dover, both of which have shown promising performance.
8. Target Downgraded Amid Economic Concerns
In a contrasting report, Bernstein has downgraded Target to an underperform rating, citing concerns over the upcoming February-to-April quarter results, hampered by poor weather and weak consumer sentiment. However, the recent tariff relief may offer some respite moving forward.
9. Affirm Stock Price Target Boost
Barclays has raised its price target for Affirm from $45 to $53, confirming its overweight buy rating following a strong quarterly performance. It’s time for the skeptics to reconsider their positions on these stocks, much like they must for Palantir.
10. CoreWeave’s Potential to Soar
Also on the radar, CoreWeave, a newly public AI cloud computing provider, has seen its price target lifted to $60 from $48 by Barclays. With earnings reports just around the corner, CoreWeave is primed for impressive growth—watch this space!
For more insights straight to your inbox, subscribe to Jim Cramer’s Top 10 Morning Thoughts on the Market newsletter. As a member of the CNBC Investing Club, you’ll receive trade alerts before Jim makes transactions, ensuring you stay ahead in the stock market arena.
This information provided in the Investing Club is subject to our terms and conditions and privacy policy, and is not a guarantee of specific outcomes or profits. Make informed decisions and trade wisely!
